Chromatin Accessibility and Transcriptional Landscape During Inhibition of by in IPEC-J2 Cells
Overview
Biophysics
Cell Biology
Molecular Biology
Affiliations
is a probiotic with bacteriostatic effects, which can effectively inhibit the activity of pathogens. However, the molecular mechanism underlying the inhibition of pathogens by in intestinal cells remains unclear. Using the porcine intestinal cell line IPEC-J2 as a model, we combined RNA-seq and ATAC-seq methods to delineate the porcine genome-wide changes in biological processes and chromatin accessibility in IPEC-J2 cells stimulated by BNCC186354, as well as ATCC 53608. Overall, we found that many porcine transcripts were altered after BNCC186354 treatment, while ATCC 53608 treatment partially restored this alteration, such as infection and PI3K/AKT and MAPK pathways. Combined analysis of these two datasets revealed that 26 genes with similar trends overlapped between gene expression and chromatin accessibility. In addition, we identified potential host functional transcription factors (TFs), such as GATA1, TAL1, TBP, RUNX1, Gmeb1, Gfi1b, RARA, and RXRG, in IPEC-J2 cells that might play a critical role and are targeted by ATCC 53608. Moreover, we verified that PI3K/AKT, MAPK, and apoptosis pathways are potentially regulated by BNCC186354 but restored by ATCC 53608. The PI3K/AKT pathway was activated by ATCC 53608, thereby potentially inhibiting BNCC186354 infection. In conclusion, our data provide new insights into the expression pattern of functional genes and the epigenetic alterations in IPEC-J2 cells underlying the bacteriostatic action of ATCC 53608.
Xiong S, Jiang J, Wan F, Tan D, Zheng H, Xue H Antioxidants (Basel). 2024; 13(4).
PMID: 38671889 PMC: 11047340. DOI: 10.3390/antiox13040441.
Cai J, Chen X, Xu C, Zhu X, Wang H, Wu S Animals (Basel). 2024; 14(5).
PMID: 38473174 PMC: 10931422. DOI: 10.3390/ani14050789.
in digestive system diseases: focus on clinical trials and mechanisms.
Peng Y, Ma Y, Luo Z, Jiang Y, Xu Z, Yu R Front Cell Infect Microbiol. 2023; 13:1254198.
PMID: 37662007 PMC: 10471993. DOI: 10.3389/fcimb.2023.1254198.